J. Leonard Lichtenfeld

945 total citations
24 papers, 679 citations indexed

About

J. Leonard Lichtenfeld is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, J. Leonard Lichtenfeld has authored 24 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Public Health, Environmental and Occupational Health and 7 papers in Immunology. Recurrent topics in J. Leonard Lichtenfeld's work include Economic and Financial Impacts of Cancer (6 papers), Global Cancer Incidence and Screening (4 papers) and Colorectal Cancer Screening and Detection (3 papers). J. Leonard Lichtenfeld is often cited by papers focused on Economic and Financial Impacts of Cancer (6 papers), Global Cancer Incidence and Screening (4 papers) and Colorectal Cancer Screening and Detection (3 papers). J. Leonard Lichtenfeld collaborates with scholars based in United States, Japan and India. J. Leonard Lichtenfeld's co-authors include Peter H. Wiernik, Michael R. Mardiney, Otis W. Brawley, Charles A. Schiffer, Anna T. Meadows, C. Everett Koop, Margaret Foti, Blasé N. Polite, Lucile L. Adams‐Campbell and Jennifer J. Griggs and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

J. Leonard Lichtenfeld

24 papers receiving 627 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Leonard Lichtenfeld United States 15 282 114 114 86 75 24 679
Lisa Stevens United States 12 327 1.2× 166 1.5× 71 0.6× 33 0.4× 37 0.5× 26 676
Genevieve Decoster Switzerland 8 477 1.7× 80 0.7× 125 1.1× 93 1.1× 191 2.5× 13 672
Anne‐Gaëlle Le Corroller France 17 323 1.1× 47 0.4× 131 1.1× 306 3.6× 81 1.1× 44 718
Roberto Rivera‐Luna Mexico 16 176 0.6× 129 1.1× 326 2.9× 141 1.6× 53 0.7× 67 808
Anne Rigg United Kingdom 13 379 1.3× 209 1.8× 71 0.6× 44 0.5× 141 1.9× 37 971
Farzad Kompani Iran 13 153 0.5× 80 0.7× 105 0.9× 49 0.6× 48 0.6× 49 610
Jun Yin United States 18 224 0.8× 156 1.4× 131 1.1× 86 1.0× 22 0.3× 77 887
R. Twombly 11 181 0.6× 99 0.9× 85 0.7× 25 0.3× 49 0.7× 72 512
Benjamin Barnes Germany 13 257 0.9× 52 0.5× 121 1.1× 86 1.0× 40 0.5× 29 530
Paul R. Massey United States 11 359 1.3× 119 1.0× 78 0.7× 36 0.4× 32 0.4× 33 788

Countries citing papers authored by J. Leonard Lichtenfeld

Since Specialization
Citations

This map shows the geographic impact of J. Leonard Lichtenfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Leonard Lichtenfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Leonard Lichtenfeld more than expected).

Fields of papers citing papers by J. Leonard Lichtenfeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Leonard Lichtenfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Leonard Lichtenfeld. The network helps show where J. Leonard Lichtenfeld may publish in the future.

Co-authorship network of co-authors of J. Leonard Lichtenfeld

This figure shows the co-authorship network connecting the top 25 collaborators of J. Leonard Lichtenfeld. A scholar is included among the top collaborators of J. Leonard Lichtenfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Leonard Lichtenfeld. J. Leonard Lichtenfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holman, Dawn M., Jessica King, Arica White, Simple D. Singh, & J. Leonard Lichtenfeld. (2023). Acral lentiginous melanoma incidence by sex, race, ethnicity, and stage in the United States, 2010–2019. Preventive Medicine. 175. 107692–107692. 8 indexed citations
2.
Bradley, Cathy J., Smita Bhatia, Julie Bynum, et al.. (2022). Policies and Practices to Address Cancer’s Long-Term Adverse Consequences. JNCI Journal of the National Cancer Institute. 114(8). 1065–1071. 5 indexed citations
3.
Parikh, Ravi B., Cathy J. Bradley, Deborah Estrin, et al.. (2022). Digital Health Applications in Oncology: An Opportunity to Seize. JNCI Journal of the National Cancer Institute. 114(10). 1338–1339. 33 indexed citations
4.
Sahar, Liora, Letícia Nogueira, Isaac Ashkenazi, et al.. (2020). When disaster strikes: The role of disaster planning and management in cancer care delivery. Cancer. 126(15). 3388–3392. 17 indexed citations
5.
Islami, Farhad, Ann Goding Sauer, Kimberly D. Miller, et al.. (2020). Cutaneous melanomas attributable to ultraviolet radiation exposure by state. International Journal of Cancer. 147(5). 1385–1390. 22 indexed citations
6.
Kaufman, Howard L., Michael B. Atkins, Prasun Subedi, et al.. (2019). The promise of Immuno-oncology: implications for defining the value of cancer treatment. Journal for ImmunoTherapy of Cancer. 7(1). 129–129. 75 indexed citations
7.
Ready, Kaylene, Katherine Johansen Taber, Natasha Bonhomme, & J. Leonard Lichtenfeld. (2019). Strategies for Improving Access to Hereditary Cancer Testing: Recommendations from Stakeholders. Genetics in Medicine. 21(8). 1702–1704. 4 indexed citations
8.
Ma, Jiemin, Ahmedin Jemal, Stacey A. Fedewa, et al.. (2019). The American Cancer Society 2035 challenge goal on cancer mortality reduction. CA A Cancer Journal for Clinicians. 69(5). 351–362. 51 indexed citations
9.
10.
12.
Cokkinides, Vilma, et al.. (2012). A profile of skin cancer prevention media coverage in 2009. Journal of the American Academy of Dermatology. 67(4). 570–575. 14 indexed citations
13.
Lichtenfeld, J. Leonard. (2011). Chemoprevention of Breast Cancer. Internal Medicine News. 44(11). 8–8. 2 indexed citations
15.
Bohlman, Mark E., J. Leonard Lichtenfeld, & Samuel M. Goldman. (1981). Lymph node calcification secondary to chemotherapy for histiocytic lymphoma.. PubMed. 50(5). 259–62. 6 indexed citations
16.
Echo, David A. Van, et al.. (1979). Phase I clinical and pharmacological study of 4'-(9-acridinylamino)-methanesulfon-m-anisidide using an intermittent biweekly schedule.. PubMed. 39(10). 3881–4. 32 indexed citations
17.
Wiernik, P H, S. C. Schimpff, Charles A. Schiffer, et al.. (1976). Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.. PubMed. 60(1). 41–53. 39 indexed citations
18.
Lichtenfeld, J. Leonard, et al.. (1976). Abnormalities of complement and its components in patients with acute leukemia, Hodgkin's disease, and sarcoma.. PubMed. 36(10). 3678–80. 27 indexed citations
19.
Schmukler, Morton, et al.. (1975). Abnormal Profile of Human Nucleolytic Activity as a Test for Cancer. JNCI Journal of the National Cancer Institute. 55(5). 1055–1059. 14 indexed citations
20.
Meadows, Anna T., J. Leonard Lichtenfeld, & C. Everett Koop. (1974). Wilms's Tumor in Three Children of a Woman with Congenital Hemihypertrophy. New England Journal of Medicine. 291(1). 23–24. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026